Hospital

Hengrui Pharmaceuticals-Backed Nanjing Tianyinshan Hospital Opens as Class 3A Oncology Specialist Center

CompanyDrug

Jiangxi Jemincare Group Secures Clinical Trial Approvals for Six Drugs in China and the US

CompanyDigital

Baidu Health and Chongqing’s Fifth People’s Hospital Collaborate on Integrated Medical Services

CompanyDeals

Suzhou Ribo Life Science Strikes Deal with Qilu Pharmaceutical for PCSK9 siRNA Drug

CompanyDeals

CStone Pharmaceuticals Regains Exclusive Rights to Tibsovo in Greater China and Singapore

CompanyDrug

Yifan Pharmaceutical’s F-652 Shows Promise in Phase II Clinical Trial for ACLF

CompanyDeals

Takeda Ends Gene Therapy Collaboration with JCR Pharmaceuticals, Returns IP

CompanyDrug

Sanofi Halts Development of Tusamitamab Ravtansine After Missed Trial Endpoints

Legal / IPPolicy / Regulatory

CNIPA Releases Updated Patent Law Rules with Pharma Industry in Focus

Policy / Regulatory

China’s CDE Issues Draft Guidelines for Overseas Drug Market Approval Filings

CompanyDeals

BMS to Acquire Karuna Therapeutics for $14 Billion, Expanding Psychosis Treatment Portfolio

Company

CStone Pharmaceuticals Disbands Sales Team for Gavreto After NRDL Setback